• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Senology Newsletter - January 15, 2013
 

Senology Newsletter - January 15, 2013

on

  • 394 views

Latest Advances in Clinical Senology and Oncology

Latest Advances in Clinical Senology and Oncology

Statistics

Views

Total Views
394
Views on SlideShare
394
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Senology Newsletter - January 15, 2013 Senology Newsletter - January 15, 2013 Document Transcript

    • Senology Newsletter Page 1 of 3 Senology.org - Newsletter International Senologic and Oncologic  Scientific Community (ISOSC)  "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Join us on LinkedIn, Twitter, Facebook, ResearchGate, Doctorsbook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions. Read the Senology.org Newspaperdaily Senology.org collaborates with "Cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation Literature Selection Skaane P et al.: "Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program", Radiology. 2013 Jan 7. [Epub ahead of print] Marinovich ML et al.: "Meta-analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy", J Natl Cancer Inst. 2013 Jan 7. [Epub ahead of print] Magbanua MJ et al.: "Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients", Cancer Res. 2013 Jan 1;73(1):30-40 Wallwiener M et al.: "The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer", Breast Cancer Res Treat. 2013 Jan;137(2):503-10 Zhu Q et al.: "Breast Cancer: Assessing Response to Neoadjuvant Chemotherapy by Using US-guided Near-Infrared Tomography", Radiology. 2012 Dec 21. [Epub ahead of print] Goss PE et al.: "Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial", Lancet Oncol. 2012 Dec 7 [Epub ahead of print] Prat A et al.: "Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer", J Clin Oncol. 2012 Dec 17. [Epub ahead of print] Zhang X et al.: "Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up", Breast Cancer Res Treat. 2013 Jan 3. [Epub ahead of print] Eliassen AH et al.: "Circulating Carotenoids and Risk of Breast Cancer: Pooled Analysis of Eight Prospective Studies", J Natl Cancer Inst. 2012 Dec 6. [Epub ahead of print]file://C:Documents and SettingsutenteDesktopStudiSenology Newsletter.htm 15/01/2013
    • Senology Newsletter Page 2 of 3 Comment "Antiviral therapy should be used in patients with HBV-related hepatocellular carcinoma after curative resection" - Chun-Ying Wu, School of Medicine, National Yang-Ming University, Taipei, Taiwan "Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection. In the present study, we found antiviral agents can reduce one-third HBV-related HCC tumor recurrence after curative liver resection for hepatitis B virus (HBV)-related HCC patients,. Based on 100,983 HCC patients in the Taiwans nationwide database, we identified 518 HBV-related HCC patients receiving nucleoside analogues and 4051 untreated HBV-related HCC patients. After adjusting competing mortality, we found the treated group had significantly reduced 6-year HCC recurrence rate and overall mortality rate. We recommend antiviral therapy should be used in HBV-related HCC patients after curative resection". (Commentary on: Wu CY et al.: "Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection", JAMA. 2012 Nov 14;308(18):1906-14) Discussion "Breast cancer screening: significant increase in cancer detection rates and decrease in false-positive rates with mammography plus tomosynthesis compared with mammography alone " - Share your opinion on LinkedIn Questions and Answers Breast Cancer Workshop Summary - with Gabriel Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Calendar of Events Breast-Gynecological International Cancer Congress, January 17-18, 2013, Cairo, Egypt 13th St. Gallen International Breast Cancer Conference, March 13-16, 2013, St. Gallen, Switzerland 5th IMPAKT Breast Cancer Conference, May 2-4, 2013, Brussels, Belgium Literature Selection Wand HM et al.: "Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy", Ann Oncol. 2013 Jan 8. [Epub ahead of print] Lindgren ME et al.: "Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients", Psychooncology. 2012 Dec 17 [Epub ahead of print] Francica G et al.: "Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients", Dig Liver Dis. 2012 Dec 12 [Epub ahead of print] Hosaka T et al.: "Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection", Hepatology. 2012 Dec 5 [Epub ahead of print] Bao Y et al.: "A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts", J Natl Cancer Inst. 2012 Dec 14. [Epub ahead of print] Pence BC et al.: "Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analysis", Cancer Epidemiol Biomarkers Prev. 2012 Dec 18. [Epub ahead of print] Thosani N et al.: "Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis", J Clin Oncol. 2012 Dec 26. [Epub ahead of print] Isham CR et al.: "Pazopanib enhances Paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer", Sci Transl Med. 2013 Jan 2;5(166):166ra3 Kinde I et al.: "Evaluation of DNA from the papanicolaou test to detect ovarian and endometrial cancers", Sci Transl Med. 2013 Jan 9;5(167):167ra4 Questions and Answersfile://C:Documents and SettingsutenteDesktopStudiSenology Newsletter.htm 15/01/2013
    • Senology Newsletter Page 3 of 3 Leukemia Workshop Summary - with Jorge Cortes, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Bladder Cancer Workshop Summary - with Steven Wong, UCLA School of Medicine, Los Angeles, CA, USA Pediatric Neuro-Oncology Workshop Summary - with Adam Levy, Childrens Hospital at Montefiore, New York, NY, USA Palliative Care Workshop Summary - with Thomas Smith, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA Melanoma Workshop Summary - with David Fisher, Massachusetts General Hospital, Boston, MA, USA Fragments of History Sidney Farber (1903–1973) showed for the first time in 1948 that folic acid antagonists could induce temporary remission in childhood leukemia (Farber S et al.: “Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-amino-pteroyl-glutamic acid (aminopterin)”, N Engl J Med 1948;238:787-793) Literature Selection Gupta J et al.: "Levonorgestrel intrauterine system versus medical therapy for menorrhagia, N Engl J Med. 2013 Jan 10;368(2):128-37 Stay informed.... Recent Advances in Clinical Medicine Gane EJ et al.: "Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C ", N Engl J Med. 2013 Jan 3;368(1):34-44 Subscribe Unsubscribe Contact Back Issues       www.senology.orgfile://C:Documents and SettingsutenteDesktopStudiSenology Newsletter.htm 15/01/2013